JP2008526188A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526188A5 JP2008526188A5 JP2007548837A JP2007548837A JP2008526188A5 JP 2008526188 A5 JP2008526188 A5 JP 2008526188A5 JP 2007548837 A JP2007548837 A JP 2007548837A JP 2007548837 A JP2007548837 A JP 2007548837A JP 2008526188 A5 JP2008526188 A5 JP 2008526188A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- protein
- promoter
- nucleic acid
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004063639.7 | 2004-12-31 | ||
| DE102004063639 | 2004-12-31 | ||
| US65108505P | 2005-02-08 | 2005-02-08 | |
| US60/651,085 | 2005-02-08 | ||
| PCT/EP2006/000009 WO2006070023A2 (en) | 2004-12-31 | 2006-01-02 | Method for reversing multiple resistance in animal cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008526188A JP2008526188A (ja) | 2008-07-24 |
| JP2008526188A5 true JP2008526188A5 (enExample) | 2009-02-19 |
| JP5584393B2 JP5584393B2 (ja) | 2014-09-03 |
Family
ID=36582063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548837A Active JP5584393B2 (ja) | 2004-12-31 | 2006-01-02 | 動物細胞における多剤耐性を逆転させる方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20100310554A1 (enExample) |
| EP (1) | EP1831382B1 (enExample) |
| JP (1) | JP5584393B2 (enExample) |
| KR (1) | KR101527213B1 (enExample) |
| CN (1) | CN101128593B (enExample) |
| AU (1) | AU2006203736B2 (enExample) |
| CA (1) | CA2592699C (enExample) |
| MX (1) | MX2007008136A (enExample) |
| SG (1) | SG158133A1 (enExample) |
| WO (1) | WO2006070023A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1655827B (zh) | 2002-05-27 | 2010-06-23 | 佩尔·松内·霍尔姆 | 腺病毒和编码其的核酸的新应用 |
| WO2005051430A1 (de) | 2003-11-14 | 2005-06-09 | Per Sonne Holm | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren |
| EP1830864A2 (de) * | 2004-12-31 | 2007-09-12 | Per Sonne Holm | E1 -minus adenoviren und deren verwendung |
| WO2010068794A2 (en) | 2008-12-10 | 2010-06-17 | The General Hospital Corporation | Hif inhibitors and use thereof |
| CN107982548A (zh) | 2012-02-07 | 2018-05-04 | 全球生物疗法有限公司 | 核酸输送的区室化方法及其组合物和应用 |
| CA2903582C (en) | 2013-03-14 | 2021-06-08 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| EP3033414A4 (en) | 2013-08-12 | 2017-03-22 | Invivosciences Inc. | Automated cell culture system and method |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| JP7015551B2 (ja) | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| US10813957B2 (en) * | 2016-10-07 | 2020-10-27 | Miami University | Engineered oncolytic viruses containing hyper-binding sites to sequester and suppress activity of oncogenic transcription factors as a novel treatment for human cancer |
| CA3045892A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| EP3610870A4 (en) * | 2017-03-31 | 2020-12-09 | Ogata, Hisanobu | METHOD OF EXPANSION OF AN ONCOLYTIC VIRUS AND ANTI-TUMOR AGENT |
| EA201990822A1 (ru) | 2017-04-12 | 2020-01-09 | Эписентарикс, Инк. | Иммуномодулирующие слитые белки |
| EP3630959A4 (en) * | 2017-05-24 | 2021-03-17 | EpicentRx, Inc. | ANTI-ANGIOGENIC ADENOVIRUS |
| CN109576231B (zh) * | 2017-09-28 | 2022-03-25 | 北京康万达医药科技有限公司 | 分离的重组溶瘤腺病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| CN113774031B (zh) * | 2020-06-10 | 2024-04-02 | 广州恩宝生物医药科技有限公司 | 一种复制型人腺病毒及其应用 |
| CN118119703A (zh) * | 2021-09-30 | 2024-05-31 | 富士胶片株式会社 | 腺相关病毒的制造方法、细胞及表达载体 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3827163B2 (ja) * | 1995-03-24 | 2006-09-27 | ジェンザイム・コーポレーション | 遺伝子治療用のアデノウイルスベクター |
| AU2319497A (en) * | 1996-03-07 | 1997-09-22 | Regents Of The University Of California, The | Helper-free, totally defective adenovirus for gene therapy |
| US6054467A (en) * | 1996-07-05 | 2000-04-25 | Sidney Kimmel Cancer Center | Down-regulation of DNA repair to enhance sensitivity to P53-mediated apoptosis |
| DK1199368T3 (da) * | 1998-07-07 | 2004-04-13 | Transgene Sa | Anvendelse af adenovirus-E4-læserammer til forbedring af ekspression af et gen af interesse |
| AU2145300A (en) * | 1998-11-18 | 2000-06-05 | Canji, Inc. | Adenoviral vectors |
| US6764674B1 (en) * | 1999-01-28 | 2004-07-20 | Onyx Pharmaceuticals Inc. | Adenovirus E1B shuttle vectors |
| DE19929569A1 (de) * | 1999-06-21 | 2000-12-28 | Holm Per Sonne | Mittel zur Behandlung maligner Erkrankungen unter Verwendung des Proteins YB-1 |
| AU6425800A (en) * | 1999-06-30 | 2001-01-22 | Max-Delbruck-Centrum Fur Molekulare Medizin | Agents for the diagnosis, prognosis and treatment of malignant diseases |
| US6955808B2 (en) * | 1999-09-24 | 2005-10-18 | Uab Research Foundation | Capsid-modified recombinant adenovirus and methods of use |
| US6635476B1 (en) * | 1999-10-15 | 2003-10-21 | Canji, Inc. | Targeted vectors |
| US7048920B2 (en) * | 2000-03-24 | 2006-05-23 | Cell Genesys, Inc. | Recombinant oncolytic adenovirus for human melanoma |
| US20030095989A1 (en) * | 2000-12-18 | 2003-05-22 | Irving John M. | Chimeric cytolytic viruses for cancer treatment |
| AU2002343901A1 (en) * | 2001-09-29 | 2003-04-14 | Kim, Joo-Hang | Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| DE10150984A1 (de) * | 2001-10-16 | 2003-04-17 | Holm Per Sonne | Verwendung des adenoviralen E2-late-Promotors |
| WO2004001032A2 (en) * | 2002-04-25 | 2003-12-31 | Crucell Holland B.V. | Stable adenoviral vectors and methods for propagation thereof |
| CN1655827B (zh) * | 2002-05-27 | 2010-06-23 | 佩尔·松内·霍尔姆 | 腺病毒和编码其的核酸的新应用 |
| JP4988199B2 (ja) * | 2002-10-15 | 2012-08-01 | ホルム，ペル・ゾンネ | 新規アデノウイルス、それをコードする核酸及びその使用 |
| US8951772B2 (en) * | 2002-10-15 | 2015-02-10 | Per Sonne Holm | Adenoviruses, nucleic acids coding therefor, and use thereof |
| CA2522380A1 (en) * | 2003-03-19 | 2004-09-30 | Isogenis, Inc. | Specific inhibition of allorejection |
| JP4871726B2 (ja) * | 2003-04-28 | 2012-02-08 | ナノシス・インク． | 超疎液性表面、その作製法及び用途 |
| WO2005051430A1 (de) * | 2003-11-14 | 2005-06-09 | Per Sonne Holm | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren |
| US20060270016A1 (en) * | 2003-11-14 | 2006-11-30 | Holm Per S | Novel adenoviruses, nucleic acids that code for the same and the use of said viruses |
| EP1830864A2 (de) | 2004-12-31 | 2007-09-12 | Per Sonne Holm | E1 -minus adenoviren und deren verwendung |
| US20070292396A1 (en) * | 2006-03-02 | 2007-12-20 | Juan Fueyo | Combination therapy with oncolytic adenovirus |
-
2006
- 2006-01-02 AU AU2006203736A patent/AU2006203736B2/en not_active Ceased
- 2006-01-02 CN CN200680006399.8A patent/CN101128593B/zh active Active
- 2006-01-02 MX MX2007008136A patent/MX2007008136A/es active IP Right Grant
- 2006-01-02 WO PCT/EP2006/000009 patent/WO2006070023A2/en not_active Ceased
- 2006-01-02 KR KR1020077017703A patent/KR101527213B1/ko active Active
- 2006-01-02 JP JP2007548837A patent/JP5584393B2/ja active Active
- 2006-01-02 EP EP06701440.7A patent/EP1831382B1/en active Active
- 2006-01-02 SG SG200908280-1A patent/SG158133A1/en unknown
- 2006-01-02 CA CA2592699A patent/CA2592699C/en active Active
-
2009
- 2009-09-09 US US12/556,560 patent/US20100310554A1/en not_active Abandoned
-
2011
- 2011-06-28 US US13/170,395 patent/US20110286999A1/en not_active Abandoned
-
2017
- 2017-03-17 US US15/461,668 patent/US11369650B2/en active Active
-
2022
- 2022-05-24 US US17/752,436 patent/US20220339219A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526188A5 (enExample) | ||
| US11268073B2 (en) | Use of adenovirus and nucleic acids coding therefor | |
| Dash et al. | mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity | |
| KR101396454B1 (ko) | 내피 세포 특이성을 나타내는 프로모터 및 이를 이용하여 혈관신생을 조절하는 방법 | |
| Zhu et al. | Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo | |
| US20100311145A1 (en) | Novel use of adenoviruses and nucleic acids that code for said viruses | |
| KR102229084B1 (ko) | 아데노바이러스를 사용하는 치료 방법 | |
| US20100151576A1 (en) | Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors | |
| JP2007511212A5 (enExample) | ||
| JP2004500880A (ja) | 肝臓特異的な遺伝子発現カセット、及びその使用法 | |
| JP2011200234A (ja) | 新規アデノウイルス、それをコードする核酸及びその使用 | |
| JP2008526189A5 (enExample) | ||
| JP2006512284A5 (enExample) | ||
| JP5435871B2 (ja) | Ｅ１−マイナスアデノウイルス及びその使用 | |
| JP5584393B2 (ja) | 動物細胞における多剤耐性を逆転させる方法 | |
| US20040242523A1 (en) | Chemo-inducible cancer gene therapy | |
| WO2012022496A2 (en) | Method for killing tumor stem cells | |
| RU2005114516A (ru) | Аденовирус с обращенной генной экспрессией и его применение | |
| Hodish et al. | Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK | |
| AU2015201828B2 (en) | Novel use of adenoviruses and nucleic acids coding therefor | |
| CN1705740B (zh) | 具有反向基因表达的腺病毒及其应用 | |
| Parikh et al. | 294. Herpes Simplex Virus Mediated Oncolysis is an Effective Intratumoral Therapy in High-Risk Neuroblastoma Tumor Models | |
| RU2004138095A (ru) | Новое применение аденовируса и кодирующих его нуклеиновых кислот |